15-17 April, 2019

The Waldorf Hilton

London, UK

Pre-Conference Covance Workshop

Operational and Commercial Considerations for CDx – A Rapidly Evolving Landscape

Tuesday, 1st May, 2018

13.00 – 17.00

Join Covance and their panel of industry expert speakers before the start of Clinical Biomarkers & World CDx Europe in this workshop to take a deeper dive into the strategy behind the commercialisation of drug-CDx products. Benefit from multi-stakeholder perspectives, granular discussion and extended networking with the brightest biomarker, precision medicine and diagnostic minds in the field. This workshop will address the following topics:

Workshop Chair: Steve Anderson, Chief Scientific Officer, Covance


Topic One: Operational / Business Models

Tom Turi, Vice President, Companion Diagnostics, Covance


Topic Two: Regulatory Realities 

Seamus Kearney, CEO & Principal Consultant, ARC Regulatory

Jo Love, Associate Senior Clinical Consultant, ARC Regulatory


Topic Three: Commercial Strategy – Global Reach and Local Expertise

Pieter Van den Steen, Chief Commercial Officer, Unilabs Group

Jakob Gjørret, CEO/MD, Unilabs Denmark


Topic Four: Newly Established and Emerging Technologies

Tuc Ahmad, Scientific Director, Diagnostic Development, Covance

Chris van Haag, Senior Manager, Strategic Accounts, Biocartis



If you are interested in joining the pre-conference workshop hosted by Covance, please email ben.carrington@hansonwade.com. If accepted, the workshop will be free to attend as part of your conference registration. Confirmation of attendance will be given via email.